Melphalan-based Conditioning

Melphalan-Based Conditioning is a reduced-intensity conditioning regimen that uses melphalan as a primary alkylating agent to selectively ablate host hematopoietic cells while minimizing non-hematopoietic toxicity in preparation for hematopoietic cell transplantation.

349

Publications

19.1K

Citations

2.8K

Authors

778

Institutions

Publications per year

2017–2026

59

Publications

349

1–5 of 349

Authors

2.8K

  1. RE
    Richard E. Champlin

    The University of Texas MD Anderson Cancer Center, United States

    20 publications · 2.1K citations

    17

    h-index

  2. UP
    Uday Popat

    The University of Texas MD Anderson Cancer Center, United States

    15 publications · 758 citations

    14

    h-index

  3. SG
    Sergio Giralt

    The University of Texas MD Anderson Cancer Center, United States

    15 publications · 1.9K citations

    14

    h-index

  4. CH
    Chitra Hosing

    The University of Texas MD Anderson Cancer Center, United States

    15 publications · 891 citations

    14

    h-index

  5. VS
    Vaishali Sanchorawala

    Boston University, United States

    13 publications · 1.4K citations

    12

    h-index

1–5 of 2.8K

Venues

  1. Biology of Blood and Marrow Transplantation

    TCT · 52 publications · 2.5K citations

    31

    h-index

  2. Bone Marrow Transplantation

    61 publications · 2.4K citations

    30

    h-index

  3. Blood

    30 publications · 4.4K citations

    22

    h-index

  4. PubMed

    Repository · 30 publications · 912 citations

    19

    h-index

  5. British Journal of Haematology

    BJH · 14 publications · 958 citations

    13

    h-index

1–5